the aid library

LIST OPTIONS

Filter

4007

Sort by:

Direction:

Download (40)

View PDF (37)

Developing respiratory pathogen pandemic preparedness plans

Pan American Health Organization (PAHO) (2024) C_WHO

Planning for public health emergencies should ensure that capabilities developed during previous emergencies are maintained, incorporated, and put into practice when a new event of public health concern arises. Investments in pandemic preparedness lead to more rapid detection and a stronger response... more

Download (86)

View PDF (209)

Development assistance for human resources for health, 1990–2020

Micah, A.E.; J. Solorio; H. Stutzman et al. Human Resources for Health (2022) C1

Background: Investing in the health workforce is key to achieving the health-related Sustainable Development Goals. However, achieving these Goals requires addressing a projected global shortage of 18 million health workers (mostly in low- and middle-income countries). Within that context, in 2016, ... more

Download (58)

View PDF (81)

“More money for health - more health for the money”: a human resources for health perspective

Campbell J.; Jones I.; Whyms D. (2011) CC

Background: At the MDG Summit in September 2010, the UN Secretary-General launched the Global Strategy for Women’s and Children’s Health. Central within the Global Strategy are the ambitions of “more money for health” and “more health for the money”. These aim to leverage more resource... more

Download (211)

View PDF (138)

Integrating the social determinants of health into health workforce education and training

World Health Organisation (WHO) (2023) C_WHO

Social inequalities are perpetuating unhealthy living and working conditions and behaviours. These causes are commonly called ‘the social determinants of health’. Achieving greater equity in health will demand that the health sector assumes a greater leadership role in addressing social inequali... more

Download (197)

View PDF (171)

Considerations for developing a national genomic surveillance strategy or action plan for pathogens with pandemic and epidemic potential

World Health Organization WHO (2023) C_WHO

Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant... more

Download (188)

View PDF (275)

Issue and Policy Intersections for Planetary Health

Panorma Perspectives (2018) C2

For the purposes of this review, we are not setting out what exactly implementing the concept of planetary health at a national level should or could look like. This is a complicated and nuanced aspect of moving the concept of planetary health to action that will be highly dependent on the unique ... more

Download (98)

View PDF (156)

WHO policy brief: Clinical management of COVID-19, 14 September 2022

World Health Organization WHO (2022) C_WHO

The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. WHO continues to support countries in adjusting COVID-19 strategies to reflect succ... more

Download (207)

View PDF (219)

Improving the Quality of PrEP Implementation for Adolescent Girls and Young Women: An implementation brief to support programming in Eastern and Southern Africa

World Health Organization WHO, Regional Office of Africa; UNICEF (2021) C_WHO

Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me... more

Download (95)

View PDF (152)

The role of community health workers in COVID-19 vaccination: Implementation support guide

World Health Organization WHO (2021) C_WHO

This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G... more

Download (74)

View PDF (746)

What you and your country can do to tackle the coronavirus crisis

80,000 hours (2020) C3

This page presents all our content related to COVID-19. It aims to: 1. Help people who want to understand or work on COVID-19 right now. 2. Help people who are considering biosecurity careers longer term. This page will focus on leveraged opportunities in research, policy, technology and startups. ... more

Download (442)

View PDF (580)

Social Science in Humanitarian Action Key considerations: Ebola preparedness and readiness in Goma, DRC

Peyton, D.; I. Gercama and J. Bedford Social Science in Humanitarian Action: A Communication for Development Platform (2019) C1

This brief summarises key considerations about the social, political and economic context of Goma in relation to the outbreak of Ebola in the DRC as of March 2019. Goma is the administrative capital of North Kivu province and a major urban centre in the Great Lakes Region. The city is home to an est... more

Download (63)

View PDF (32)

High Blood Pressure in Pregnancy

MedlinePlus National Library of Medicine (2019) CC

What is high blood pressure in pregnancy? Blood pressure is the force of your blood pushing against the walls of your arteries as your heart pumps blood. High blood pressure, or hypertension, is when this force against your artery walls is too high. There are different types of high blood pressure ... more

Download (261)

View PDF (356)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (157)

View PDF (354)

Addressing Inequalities in Global Health: UNU IIGH Strategic Plan 2024–2028

United Nations University UNU (2024) C1

The 2019-2023 Strategy for UNU-IIGH, developed in 2018, built on UNU-IIGH’s strategic advantage and position vis-à-vis the UN and global health ecosystem. The Strategy set a goal to advance evidencebased policy on key issues related to sustainable development and health and shifted the Instit... more

Download (199)

View PDF (213)

Strengthening primary health care to tackle racial discrimination, promote intercultural services and reduce health inequities

World Health Organization WHO (2022) C_WHO

As countries aim to progress towards the Sustainable Development Goals (SDGs) and achieving universal health coverage, health inequities driven by racial discrimination and intersecting factors remain pervasive. Inequities experienced by indigenous peoples as well as people of African descent, Roma ... more

Download (149)

View PDF (157)

The Practical Approach to Care Kit (PACK) guide: developing a clinical decision support tool to simplify, standardise and strengthen primary health care delivery

Cornick, Picken, Wattrus et al. BMJ Global Health Journal (2018) CC

For the primary health worker in a low/middle-income country (LMIC) setting, delivering quality primary care is challenging. This is often complicated by clinical guidance that is out of date, inconsistent and informed by evidence from high-income countries that ignores LMIC resource constraints and... more

Download (88)

View PDF (639)

Medical Ethics and Bedside Rationing in Low‐Income Countries: Challenges and Opportunities

Kapiriri, L. ResearchGate (2017) CC

Bioethics - Medical, Ethical and Legal Perspectives There’s evidence that implementing the four medical ethics principles may be challenging especially in low income country contexts with extreme resource scarcity and limited capacity to facilitate deliberations on the different ethical dilemmas.... more

Download (26)

View PDF (27)

Cancer: Disease Control Priorities, Third Edition (Volume 3)

Gelband H., Jha P., Sankaranarayanan R. et al. International Bank for Reconstruction and Development The World Bank (2015) C2

Volume 3, Cancer, presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packa... more

Download (750)

View PDF (786)

Viral Hepatitis. Arabic.

Health Information Translations (2015) C1

Download (967)

View PDF (2819)

Lavez-vous les mains

Ministère de la santé publique de l'État du Massachusetts (2004)